The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Baxter International Inc

NYSE: BAX
Last

(U.S.) $70.01

Today's change+0.81 +1.17%
Updated January 19 4:00 PM EST. Delayed by at least 15 minutes.
 

Baxter International Inc

NYSE: BAX
Last

(U.S.) $70.01

Today's change+0.81 +1.17%
Updated January 19 4:00 PM EST. Delayed by at least 15 minutes.

Baxter International Inc Hits New 52-week High

Baxter International Inc closed up Friday by (U.S.)$0.81 or 1.17% to (U.S.)$70.01 and setting a new 52-week high. Over the last five days, shares have gained 2.44% and outperformed the S&P 500 index over the last 52 weeks with a 50.33% increase in price.

Key company metrics

  • Open(U.S.) $69.36
  • Previous close(U.S.) $69.20
  • High(U.S.) $70.02
  • Low(U.S.) $69.36
  • Bid / Ask-- / --
  • YTD % change+8.31%
  • Volume3,530,470
  • Average volume (10-day)3,048,014
  • Average volume (1-month)2,826,377
  • Average volume (3-month)2,558,854
  • 52-week range(U.S.) $45.47 to (U.S.) $70.02
  • Beta0.77
  • Trailing P/E37.75×
  • P/E 1 year forward28.80×
  • Forward PEG2.13×
  • Indicated annual dividend(U.S.) $0.64
  • Dividend yield0.91%
  • Trailing EPS(U.S.) $1.85
Updated January 19 4:00 PM EST. Delayed by at least 15 minutes.
S&P TSX0.42%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201709/30/2017Jun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016
Revenue2,7072,6052,4752,645
Total other revenue--------
Total revenue2,7072,6052,4752,645
Gross profit1,1861,1411,0581,139
Total cost of revenue1,5211,4641,4171,506
Total operating expense2,4152,2992,1312,363
Selling / general / administrative633603560619
Research & development152157126152
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)109752886
Other operating expenses, total--------
Operating income292306344282
Interest income (expense), net non-operating-22-21-20-20
Gain (loss) on sale of assets--------
Other--------
Income before tax290306328279
Income after tax248264273240
Income tax, total42425539
Net income251265272243
Total adjustments to net income--------
Net income before extra. items248264273240
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items248264273240
Inc. avail. to common incl. extra. items251265272243
Diluted net income251265272243
Dilution adjustment--------
Diluted weighted average shares557555551548
Diluted EPS excluding extraordinary itemsvalue per share0.450.480.500.44
Dividends per sharevalue per share0.160.160.130.13
Diluted normalized EPSvalue per share0.570.560.520.57